Dr. Jonathan Silverberg talks about the maintenance data from REZOLVE-AD trial showing lasting efficacy in patients treated with rezpegaldesleukin across several disease measurements of atopic dermatitis (AD).
advertisement
Rezpegaldesleukin for the Treatment of Atopic Dermatitis
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Jonathan Silverberg talks about the maintenance data from REZOLVE-AD trial showing lasting efficacy in patients treated with rezpegaldesleukin across several disease measurements of atopic dermatitis (AD).
Title
Program Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?